Does Dr. ASHISH AGRAWAL have financial conflicts of interest?

Dr. ASHISH AGRAWAL (M.D.) has received a total of $1,626 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,626 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ASHISH AGRAWAL?

According to CMS Open Payments data, Dr. ASHISH AGRAWAL received funding from UNITED THERAPEUTICS CORPORATION ($325), ACTELION PHARMACEUTICALS US ($236), and GETINGE USA SALES ($182).

Does Dr. ASHISH AGRAWAL receive research grants or speaking fees?

Dr. ASHISH AGRAWAL has received $1,626 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ASHISH AGRAWAL

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: LA MESA, CA 91942

NPI Number: 1225136484

LIFETIME INDUSTRY VALUE

$1,626

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGRAWAL is a verified Internal Medicine, Pulmonary Disease practitioner based in LA MESA, CA.

Between 2021 and 2024, Dr. AGRAWAL had an overall industry promotional and research financial footprint of $1,626 as recorded in the federal CMS Open Payments database.

$1,626 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGRAWAL's primary funding source is UNITED THERAPEUTICS CORPORATION, which accounts for $325 (representing 20% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

UNITED THERAPEUTICS CORPORATION

Rank 1

$325

20%

ACTELION PHARMACEUTICALS US

Rank 2

$236

14.5%

GETINGE USA SALES

Rank 3

$182

11.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.